Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_assertion type Assertion NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_head.
- NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_assertion description "[In contrast, elderly MDR1+ de novo AML patients and elderly MDR1+ patients with secondary AML are much less likely to achieve a complete response with current regimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_provenance.
- NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_assertion evidence source_evidence_literature NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_provenance.
- NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_assertion SIO_000772 8618468 NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_provenance.
- NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_assertion wasDerivedFrom befree-20150227 NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_provenance.
- NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_assertion wasGeneratedBy ECO_0000203 NP618579.RAWuXhNJzX5JKpEZEKHnR2uVKFN3m1SDEjGydY1PeISvs130_provenance.